Oxford Asset Management’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q3 | – | Sell |
-152,817
| Closed | -$2.29M | – | 947 |
|
|
2016
Q2 | $2.29M | Buy |
152,817
+121,945
| +395% | +$1.83M | 0.08% | 342 |
|
|
2016
Q1 | $376K | Buy |
+30,872
| New | +$376K | 0.01% | 651 |
|
|
2015
Q3 | – | Sell |
-140,684
| Closed | -$3.42M | – | 784 |
|
|
2015
Q2 | $3.42M | Buy |
140,684
+72,730
| +107% | +$1.77M | 0.09% | 240 |
|
|
2015
Q1 | $1.58M | Sell |
67,954
-68,195
| -50% | -$1.59M | 0.04% | 396 |
|
|
2014
Q4 | $3.43M | Buy |
136,149
+65,466
| +93% | +$1.65M | 0.08% | 261 |
|
|
2014
Q3 | $2.2M | Sell |
70,683
-14,285
| -17% | -$444K | 0.05% | 353 |
|
|
2014
Q2 | $2.18M | Buy |
+84,968
| New | +$2.18M | 0.07% | 357 |
|
|
2014
Q1 | – | Sell |
-124,065
| Closed | -$3.15M | – | 851 |
|
|
2013
Q4 | $3.15M | Sell |
124,065
-138,343
| -53% | -$3.51M | 0.08% | 336 |
|
|
2013
Q3 | $5.35M | Buy |
262,408
+227,866
| +660% | +$4.65M | 0.12% | 222 |
|
|
2013
Q2 | $725K | Buy |
+34,542
| New | +$725K | 0.02% | 640 |
|